EUVIMEDEUVIMED entdecken
Crossref

Isoquercetin Ameliorates Osteoarthritis via Nrf2/ NF ‐ κB Axis: An In Vitro and In Vivo Study

He Yu, Junsheng Lou, Libin Ni, Minwei Yan, Kewu Zhu, Su Mao, Jungao Zhu iD

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.14620 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von He Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Zhejiang Hospital, Zhejiang, Hangzhou, China. Hauptthemen laut MEDLINE: Chondrocytes, NF-E2-Related Factor 2, NF-kappa B, Osteoarthritis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Zhejiang Province Traditional Chinese Medicine Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a progressive joint disease characterized by extracellular matrix (ECM) degradation and inflammation, which is involved with pathological microenvironmental alterations induced by damaged chondrocytes. However, current therapies are not effective in alleviating the progression of OA. Isoquercetin is a natural flavonoid glycoside compound that has various pharmacological effects including anticancer, anti‐diabetes and blood lipid regulation. Previous evidence suggests that isoquercetin has anti‐inflammatory properties in various diseases, but its effect on OA has not been investigated yet. In this study, through western bolt, qRT‐PCR and ELISA, it was found that isoquercetin could reduce the increase of ADAMTS5, MMP13, COX‐2, iNOS and IL‐6 induced by IL‐1β, suggesting that isoquercetin could inhibit the inflammation and ECM degradation of chondrocytes. Through nuclear‐plasma separation technique, western blot and immunocytochemistry, it can be found that Nrf2 and NF‐κB pathways are activated in this process, and isoquercetin may rely on this process to play its protective role. In vivo, the results of X‐ray and SO staining show that intra‐articular injection of isoquercetin reduces the degradation of cartilage in the mouse OA model. In conclusion, the present work suggests that isoquercetin may benefit chondrocytes by regulating the Nrf2/NF‐κB signaling axis, which supports isoquercetin as a potential drug for the treatment of OA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChondrocytesNF-E2-Related Factor 2NF-kappa BOsteoarthritisQuercetinSignal TransductionAnimalsHumansMaleMiceADAMTS5 ProteinAnti-Inflammatory AgentsCyclooxygenase 2Interleukin-1betaInterleukin-6Matrix Metalloproteinase 13Mice, Inbred C57BLNitric Oxide Synthase Type II

Stichwörter der Autor:innen

NF‐κBchondrocytesinflammationisoquercetinosteoarthritis

Substanzen

ADAMTS5 ProteinAnti-Inflammatory AgentsCyclooxygenase 2Interleukin-1betaInterleukin-6Matrix Metalloproteinase 13NF-E2-Related Factor 2NF-kappa BNfe2l2 protein, mouseNitric Oxide Synthase Type II

Autor:innen und Institutionen

  • Department of Orthopaedics, Zhejiang Hospital, Zhejiang, Hangzhou, China.
  • Department of Orthopedic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou, China.
  • Center for Drug Delivery System Research, School of Medicine, Shaoxing University, Shaoxing, Zhejiang, China.

ORCID-Profile: Jungao Zhu

Förderung

  • Zhejiang Province Traditional Chinese Medicine Science and Technology Project

Zitieren

APA

Yu, H., Lou, J., Ni, L., Yan, M., Zhu, K., Mao, S., & Zhu, J. (2024). Isoquercetin Ameliorates Osteoarthritis via Nrf2/ NF ‐ κB Axis: An In Vitro and In Vivo Study. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14620

Vancouver

Yu H, Lou J, Ni L, Yan M, Zhu K, Mao S, et al. Isoquercetin Ameliorates Osteoarthritis via Nrf2/ NF ‐ κB Axis: An In Vitro and In Vivo Study. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14620

BibTeX
@article{Yu2024,
  author = {Yu, He and Lou, Junsheng and Ni, Libin and Yan, Minwei and Zhu, Kewu and Mao, Su and Zhu, Jungao},
  title = {Isoquercetin Ameliorates Osteoarthritis via Nrf2/ NF ‐ κB Axis: An In Vitro and In Vivo Study},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.14620}
}
Kostenlos starten →